Israel Englander Johnson & Johnson Call Options Transaction History

Millennium Management LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$145.48 - $167.38 $20.9 Million - $24.1 Million	-144,000 Reduced 20.89%	545,200 $88.4 Million
Q2 2024 Aug 14, 2024	SELL	$144.38 - $157.78 $42.1 Million - $46 Million	-291,500 Reduced 29.72%	689,200 $101 Million
Q1 2024 May 15, 2024	BUY	$155.22 - $162.74 $23.3 Million - $24.5 Million	150,300 Added 18.1%	980,700 $155 Million
Q4 2023 Feb 14, 2024	SELL	$145.6 - $158.88 $76 Million - $82.9 Million	-521,800 Reduced 38.59%	830,400 $130 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $63.5 Million - $68.4 Million	411,600 Added 43.76%	1,352,200 $224 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $60 Million - $71.6 Million	-397,100 Reduced 29.69%	940,600 $146 Million
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $87 Million - $97.7 Million	543,200 Added 68.37%	1,337,700 $236 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $26.9 Million - $29.9 Million	166,800 Added 26.57%	794,500 $130 Million

4,271

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.